Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Intervalo de año de publicación
1.
Biomater Sci ; 11(12): 4346-4358, 2023 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-37140070

RESUMEN

Monotherapy of lung cancer shows limited therapeutic effects due to its poorly targeted enrichment and low bioavailability. Using nanomaterials as carriers to form drug delivery systems has become a popular method to improve the targeting of anticancer drug therapy and patients' safety. However, the uniformity of the loaded drugs and the unsatisfactory effects are still the bottleneck in this field up to now. This study aims to construct a novel nanocomposite carrying 3 different types of anticancer drugs to enhance treatment efficacy. Herein, mesoporous silica (MSN) with high loading rate was constructed by dilute sulfuric acid thermal etching as the framework. Hyaluronic acid (HA) was loaded with CaO2, p53 and DOX to construct nanoparticle complexes-SiO2@CaO2@DOX@P53-HA. First, MSN was proved to be a porous sorbent with a mesoporous structure through BET analysis. The images obtained from the uptake experiment clearly show the gradual enrichment of the DOX and Ca2+ within the target cell. For in vitro experiments, the pro-apoptotic effects of SiO2@CaO2@DOX@P53-HA significantly increased compared to that of the single-agent group at different time points. Furthermore, in the tumor-bearing mouse experiment, the tumor volume was remarkably inhibited in the SiO2@CaO2@DOX@P53-HA group compared to that in the single-agent group. By observing the pathological sections of the euthanized mice, it is obvious that the tissues of the mice treated with the nanoparticles were more intact. Based on these beneficial results, it is believed that multimodal therapy is a meaningful treatment strategy for lung cancer.


Asunto(s)
Neoplasias Pulmonares , Nanopartículas , Ratones , Animales , Doxorrubicina/farmacología , Doxorrubicina/uso terapéutico , Ácido Hialurónico/química , Dióxido de Silicio/química , Proteína p53 Supresora de Tumor/genética , Sistemas de Liberación de Medicamentos/métodos , Neoplasias Pulmonares/tratamiento farmacológico , Nanopartículas/química , Portadores de Fármacos/química
2.
Am J Transl Res ; 12(2): 379-388, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32194890

RESUMEN

Immunotherapy using antibodies blocking the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway has achieved great success in preclinical models and the clinical treatment of esophageal squamous cell carcinoma (ESCC). The c-Myc proto-oncogene helps prevent immune cells from attacking tumor cells by inducing PD-L1 expression. However, the underlying mechanisms of c-Myc and PD-L1 in ESCC remain unclear, and a thorough understanding of this regulation would allow the development of new approaches to enhance antitumor immunity. In the present study, the positive relationship between c-Myc and PD-L1 was explored in the Cancer Genome Atlas dataset using the bioinformatics tool GEPIA, and was confirmed in 105 ESCC tissues by immunostaining (r=0.516, P<0.001). The patients positive for both proteins had a poorer overall survival (P=0.032). Furthermore, in ESCC cell lines, c-Myc overexpression, depletion, and inhibition was able to regulate the expression of PD-L1. Also, the ChIP assays showed that the increase in PD-L1 expression was likely due to the binding of c-Myc to the PD-L1 promoter. Taken together, c-Myc and PD-L1 levels were significantly correlated, and c-Myc expression regulated the expression of PD-L1 in ESCC cells. In addition, a small molecule inhibitor of c-Myc effectively regulated PD-L1 expression. This indicates that synergistic therapy combining a c-Myc inhibitor with PD-L1 immunotherapy might be a promising new treatment strategy for ESCC.

3.
Chinese Journal of School Health ; (12): 1882-1885, 2020.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-862236

RESUMEN

Objective@#The purpose of this study is to explore a school-based comprehensive intervention for abnormal body posture in adolescents.@*Methods@#The study recruited from 3 senior high schools in Xicheng District of Beijing using random clustering method and randomly divided them into intervention group (n=213) and control group (n=227). The intervention group adopted a comprehensive intervention program for 16 weeks, while the control group maintained normal teaching plan. The comprehensive intervention included distributing booklet regarding body posture, health lectures and corrective exercise in physical classes. Before and after the intervention, forward head posture, shoulder asymmetry, rounded shoulder and sagittal angles of spine of subjects were evaluated.@*Results@#After 16 weeks intervention, shoulder asymmetry [boys(0.98±0.52)(0.70±0.44)cm; girls(1.00±0.67)(0.72±0.44)cm], forward head posture [boys(8.24±2.71)(4.73±2.99)cm; girls(9.14±2.56)(4.39±2.34)cm] and the differences of distance between left and right inferior angel of scapula and spine [boys(0.41±0.39)(0.28±0.30)cm; girls(0.52±0.38)(0.28±0.19)cm] of the intervention group were significantly improved(t=2.33, 3.07, 9.80, 11.51, 2.36, 4.61, P<0.05). The proportion of normal thoracic kyphosis angle and lumbar lordosis angle increased in girls of intervention group (63.4%, 95.7%), while these proportion decreased in boys of intervention group (74.2%, 65.0%).@*Conclusion@#School-based intervention including health education and exercise shows effectiveness on abnormal body posture in adolescents, which is recommended school.

4.
World J Surg Oncol ; 17(1): 23, 2019 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-30691475

RESUMEN

BACKGROUND: Osteosarcoma is a malignant bone tumor with a high potential for lung metastasis, and the prognosis for patients with metastatic disease is very poor. The interaction between fibronectin (FN) and integrin αvß3 in soft-tissue sarcoma promotes cell migration, invasion, and lung metastasis. This study aimed to investigate the prognostic significance of FN and αvß3 in osteosarcoma. METHODS: Immunohistochemistry and western blotting were used to detect the expression of FN and αvß3 in 60 osteosarcoma specimens and in 30 osteochondroma specimens. Furthermore, correlations of FN and αvß3 with the clinicopathological features of osteosarcoma patients were analyzed using the χ2 test and Fisher's exact test. Disease-free survival and overall survival of osteosarcoma patients were assessed using the Kaplan-Meier method and Cox proportional hazards model. The predictive accuracy of the model was determined by the Harrell concordance index. RESULTS: FN (P < 0.05) and αvß3 (P < 0.05) were overexpressed in osteosarcoma specimens compared with osteochondroma specimens. High FN expression was associated with a poor response to chemotherapy (P = 0.001) and poor disease-free (P < 0.001) and overall (P < 0.001) survival. High expression of αvß3 was linked to an advanced surgical stage (P = 0.028), a poor response to chemotherapy (P = 0.002), and both poor disease-free survival (P < 0.001) and overall survival (P < 0.001). FN and αvß3 co-expression were associated with sex (P = 0.011), an advanced surgical stage (P = 0.013), and a poor response to chemotherapy (P = 0.002). Moreover, high expression of both proteins can serve as an independent prognostic value for reduced survival time in osteosarcoma patients. CONCLUSIONS: The results of this study suggest that FN and αvß3 expression is associated with an unfavorable clinical outcome of osteosarcoma, and these molecules may constitute attractive therapeutic targets for osteosarcoma treatment. To improve the survival of osteosarcoma patients, further investigations are required to clarify their prognostic values in a larger population.


Asunto(s)
Neoplasias Óseas/patología , Fibronectinas/análisis , Integrina alfaVbeta3/análisis , Osteosarcoma/patología , Adulto , Anciano , Neoplasias Óseas/química , Neoplasias Óseas/mortalidad , Supervivencia sin Enfermedad , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Osteosarcoma/química , Osteosarcoma/mortalidad , Pronóstico
5.
Oncol Lett ; 17(2): 1565-1572, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30675214

RESUMEN

Osteosarcoma (OS) is the most common primary malignant bone tumor. Numerous studies have strongly implicated the ectopic expression of microRNAs (miRNAs/miRs), including miR-885-5p, which is aberrantly expressed in several cancer types, in multiple cancer-related processes. However, the role of miR-885-5p in OS remains unknown. In the present study, it was found that the expression of miR-885-5p was markedly upregulated in OS cell lines and clinical tissues. Moreover, high expression of miR-885-5p was significantly associated with the development of OS. The human OS MG-63 cell line was transfected with recombinant lentivirus to regulate miR-885-5p expression. Overexpressed miR-885-5p significantly promoted the proliferation and migration of MG-63 cells in vitro, while downregulating miR-885-5p expression reversed these effects. Furthermore, bioinformatic analysis was used to predict the potential target genes of miR-885-5p, and cell division cycle protein 73 homolog (CDC73) was identified as a novel and direct target of miR-885-5p. This interaction was further confirmed using reverse transcription-quantitative polymerase chain reaction, western blotting and luciferase activity assays. These findings suggest that miR-885-5p serves a critical role in facilitating OS proliferation and migration, and can regulate CDC73 expression in OS cells and tissues. Thus, miR-885-5p could be a promising novel therapeutic biomarker for OS.

6.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-819368

RESUMEN

Objective@#To evaluate physical load of different sports and in various forms of physical education class.@*Methods@#117 healthy adolescents (57 girls and 60 boys) were recruited from 6 high schools in Xicheng District of Beijing (2 high schools of type 1, 2 of type 2, and 2 of type 3), and each 10 students were randomly selected from grade 1 and 2 in the high school. Polar Team 2 was used to measure physiological load in martial arts, throwing, jumping and basketball, and 639 persontime eligible data were collected.@*Result@#In martial arts and high jump class, duration of heart rate response (HRmax) below 60% in the new classes were significantly longer, while duration of moderatetovigorous physical activity (MVPA) was shorter than comprehensive courses and review courses(P<0.05). Students spent about an average of 24.6 (9-34) minutes in activities of HRmax below 60% in P.E.class, accounting for 54.7% of P.E. class time, an average of 17.3 (7-26) minutes in activities of HRmax between 60%-80%, accounting for 38.4% of P.E. class time, and an average of 3.5 (0-20) minutes in activities of HRmax higher than 80%, accounting for 6.9% of P. E. class time.@*Conclusion@#This physical load cannot achieve the goal of improving adolescents’ physical fitness. Government should strengthen the continuing education of PE teachers and update their knowledge constantly, in order to maximize the physical education benefit for adolescents.

7.
Oncol Lett ; 16(2): 2185-2194, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30008917

RESUMEN

The prognosis of patients with metastatic osteosarcoma is poor and has shown no significant improvement in nearly 20 years. The human epidermal growth factor (EGF) receptor (HER) family is frequently overexpressed in the majority of human carcinomas, and is involved in promoting the proliferation and survival of cancer cells. However, the role of EGFR and HER-2 expression in osteosarcoma survival remains controversial and no previous study has simultaneously investigated the association of the expression of all the four HER family members with the prognostic significance of osteosarcoma. Therefore, the present study investigated the expression levels of the complete members of the HER family in osteosarcoma specimens, as well as their associations with the clinicopathological parameters, progression-free survival (PFS) and overall survival (OS) time of patients with osteosarcoma. The expression of HER family members was detected in osteosarcoma tumor specimens from 60 patients using immunohistochemistry. The association of the expression of HER receptors in osteosarcoma with clinicopathological parameters was analyzed using χ2 test and Fishers exact test. Survival analyses were evaluated by Kaplan-Meier method and Cox proportional hazards regression model. Overall, 18 (30%), 13 (22%), 23 (38%) and 19 (32%) patients presented with high expression of EGFR, HER-2, HER-3 and HER-4, respectively, and the co-expression of 2, 3 and all 4 members of the HER family was observed. High expression of EGFR and HER-4 was associated with distant metastasis. High HER-3 expression was significantly associated with an advanced Enneking stage and distant metastasis. Multivariate analysis demonstrated that the expression of EGFR, HER-3, HER-4, EGFR/HER-3, EGFR/HER-4 and HER-3/HER-4 was an independent predictor of poor PFS and OS time in osteosarcoma patients with stage I-IIB disease. In patients with stage IIB osteosarcoma, the expression of HER-4 and EGFR/HER-4 demonstrated a more significant effect on PFS and OS time. In conclusion, therapies targeting EGFR, HER-3 and HER-4 may provide promising strategies for primary osteosarcoma.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...